RIVERSIDE REHABILITATION INSTITUTE — History
CCN 493027 | 3-year financial timeline | COVID resilience: 58/100
🛡️ Public data only — no PHI permitted on this instance.
$26M
Latest Revenue (FY2022)
+11.9%
Revenue CAGR (3yr)
8.5%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $21M | $24M | $26M | +8.0% | +11.9% |
| Operating Expenses | $18M | $22M | $24M | +8.2% | +15.0% |
| Operating Margin | 13.3% | 8.7% | 8.5% | -2.7% | -20.3% |
| Net Income | $3M | $2M | $2M | +5.1% | -10.9% |
| Licensed Beds | 50 | 50 | 50 | +0.0% | +0.0% |
| Total Patient Days | 13,496 | 14,272 | 14,962 | +4.8% | +5.3% |
| Medicare Day % | 55% | 55% | 58% | +5.0% | +2.4% |
| Medicaid Day % | 2% | 2% | 2% | -19.7% | +0.0% |
COVID Impact & Recovery
Resilience Score: 58/100 — Moderate — some COVID impact but recovering
Revenue recovery from FY2020 to FY2022: +25.2% ($21M → $26M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▼ Declining
vs State Average ()
Revenue Growth
+11.9%
This Hospital
+7.6%
State Avg
Latest Margin
8.5%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $29M | 6.0% |
| FY2024 (proj) | $31M | 3.6% |
| FY2025 (proj) | $34M | 1.2% |